A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study

NCT02013089 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancers

Interventions

DRUG: Erlotinib or Gefitinib
DRUG: Everolimus
DRUG: Imatinib
DRUG: Sorafenib or Sunitinib
DRUG: Vandetanib

Sponsor

Sun Yat-sen University